New: NCI-funded clinical trial search
Mednet Logo

When using IV TNF inhibitors, do you follow levels to determine if the current dose is adequately treating the patient?

Do you treat through low-level antibodies?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Rheumatology · University of Alabama Birmingham
Answered on

I tend not to get levels, but rather I rely on clinical response; if partial response, often increasing dose (or shorten intervals) can provide dramatic benefit. If the prior response is lost, then consider getting levels and checking for HACAs. I often use TNFi with csDMARDs (e.g., weekly SC methot...

Join for free or sign in to see the full answer